VYVANSE Demonstrated Significant Improvement In ADHD Symptoms In Adults Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints. "Adults with ADHD often find it challenging to focus and organize during the day.
Source: www.medicalnewstoday.comNot In My Back Garden - Government Figures Show Mental Health Stigma Is Still Rife, UK Mental
health charity Rethink has branded findings released by the Department of
Health on attitudes towards people with mental
health problems as "shocking, ignorant, and unacceptable in today's society.
Source: www.medicalnewstoday.comLabels: No Prescription, Online Pharmacy
# posted by Network @ 10:00 AM
